Euronext Amsterdam

VEON appoints Joop Brakenhoff as Group Chief Financial Officer

Retrieved on: 
Wednesday, March 15, 2023
CFO, Euronext Amsterdam, Internal, Internal audit, Audit, Growth, VEON, Ahold, Financial management, Heineken N.V., Chief, KPMG, Management

Amsterdam, 15 March 2023: VEON Ltd. (NASDAQ: VEON, Euronext Amsterdam: VEON), a global digital operator that provides converged connectivity and online services, today announces the appointment of Joop Brakenhoff as Group Chief Financial Officer (CFO), effective from 1 May 2023.

Key Points: 
  • Amsterdam, 15 March 2023: VEON Ltd. (NASDAQ: VEON, Euronext Amsterdam: VEON), a global digital operator that provides converged connectivity and online services, today announces the appointment of Joop Brakenhoff as Group Chief Financial Officer (CFO), effective from 1 May 2023.
  • Joop will replace Serkan Okandan whose three-year contract as Group CFO is set to expire at the end of April 2023.
  • Serkan will continue to serve VEON as a special advisor to the Group CEO and CFO.
  • Joop brings more than 35 years of experience to VEON, including serving most recently as the Company’s Group Chief Internal Audit & Compliance Officer and prior to that, Head of Internal Audit.

DSM - delivery of shares

Retrieved on: 
Tuesday, March 14, 2023
Animal, Nutrition, Exchange, Offering circular, Euronext Amsterdam, Royal, DSM (company), DSM, Treasury, Exercise, Security (finance), Health

HEERLEN, Netherlands, March 14, 2023 /PRNewswire/ -- Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options.

Key Points: 
  • This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options.
  • Pursuant to commitments entered into prior to issuing the Offering Circular, DSM has on 14 March 2023, delivered 295 ordinary shares to employees in view of settling the exercise of an equivalent number of stock options granted under the respective DSM Incentive Plan (average exercise price €93.29).
  • On the date hereof, the total number of issued and outstanding DSM ordinary shares is 173,147,272.
  • As a consequence of the delivery included herein, the number of outstanding DSM ordinary shares increased by 0.0002%.

DSM - delivery of shares

Retrieved on: 
Monday, March 13, 2023
DSM (company), Animal, Nutrition, Exchange, Royal, DSM, Exercise, Euronext Amsterdam, Treasury, Offering circular, Security (finance), Health

HEERLEN, Netherlands, March 13, 2023 /PRNewswire/ -- Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options.

Key Points: 
  • This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options.
  • Pursuant to commitments entered into prior to issuing the Offering Circular, DSM has on 13 March 2023, delivered 240 ordinary shares to employees in view of settling the exercise of an equivalent number of stock options granted under the respective DSM Incentive Plan (average exercise price €98.00).
  • On the date hereof, the total number of issued and outstanding DSM ordinary shares is 173,146,977.
  • As a consequence of the delivery included herein, the number of outstanding DSM ordinary shares increased by 0.0001%.

Pharming Group announces that it expects to have full access today to its cash on deposit at Silicon Valley Bank Limited in light of UK Government announcement

Retrieved on: 
Monday, March 13, 2023
Banking Act 2009, Pharming, HSBC, SVB, Silicon, Bank, Euronext, Euronext Amsterdam, US, Government, Treasury

LEIDEN, Netherlands, March 13, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") ( Euronext Amsterdam: PHARM / Nasdaq: PHAR) is aware that Silicon Valley Bank Limited ("SVB UK") has today been sold to HSBC UK Bank plc.

Key Points: 
  • LEIDEN, Netherlands, March 13, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") ( Euronext Amsterdam: PHARM / Nasdaq: PHAR) is aware that Silicon Valley Bank Limited ("SVB UK") has today been sold to HSBC UK Bank plc.
  • This transaction has been facilitated by the Bank of England, in consultation with the Treasury, using powers granted by the Banking Act 2009.
  • The announcement by the UK government states that  customer deposits have been protected and that customers of SVB UK will be able to access their deposits and banking services as normal from today.
  • As a result of these actions, Pharming expects to have access to the US$19 million it has on deposit at SVB UK, and to not bear any losses on these deposits.

Pharming Group announces that it expects to have full access today to its cash on deposit at Silicon Valley Bank in light of US Government announcement

Retrieved on: 
Monday, March 13, 2023
Federal Deposit Insurance Corporation, Federal Reserve, Pharming, SVB, Silicon, Euronext Amsterdam, Bloomberg L.P. v. Board of Governors of the Federal Reserve System, FDIC, Silicon Valley Bank, Treasury, Structure of the Federal Reserve System, Bank

LEIDEN, Netherlands, March 13, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) (NASDAQ: PHAR) is aware that the US Department of the Treasury, the Board of Governors of the Federal Reserve System and the Federal Deposit Insurance Corporation ("FDIC") issued a joint statement on March 12, 2023 stating that actions have been approved enabling the FDIC to complete its resolution of Silicon Valley Bank ("SVB US") in a manner that fully protects all depositors.

Key Points: 
  • LEIDEN, Netherlands, March 13, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) (NASDAQ: PHAR) is aware that the US Department of the Treasury, the Board of Governors of the Federal Reserve System and the Federal Deposit Insurance Corporation ("FDIC") issued a joint statement on March 12, 2023 stating that actions have been approved enabling the FDIC to complete its resolution of Silicon Valley Bank ("SVB US") in a manner that fully protects all depositors.
  • The statement further noted that depositors will have access to all of their money starting today.
  • As a result of these actions, Pharming expects to have access to the US$26 million it has on deposit at SVB US, and to not bear any losses on these deposits.
  • Pharming continues to actively monitor the situation, including with respect to its US$19 million in deposits at Silicon Valley Bank UK Limited.

VEON to Accelerate Digital Operator Roll-Out with Appointment of Group DO1440 Officer

Retrieved on: 
Thursday, March 9, 2023
Education, Euronext Amsterdam, Health, MWC, Human, VEON, Connected, Cryptocurrency

Amsterdam, Netherlands, 9th March 2023 - VEON Ltd. (NASDAQ: VEON, Euronext Amsterdam: VEON), a global digital operator that provides converged connectivity and online services, today announces it has appointed a dedicated Group DO1440 Officer, Lasha Tabidze, to support its operating companies in executing its digital operator model.

Key Points: 
  • Amsterdam, Netherlands, 9th March 2023 - VEON Ltd. (NASDAQ: VEON, Euronext Amsterdam: VEON), a global digital operator that provides converged connectivity and online services, today announces it has appointed a dedicated Group DO1440 Officer, Lasha Tabidze, to support its operating companies in executing its digital operator model.
  • In his Group DO1440 Officer role, Mr. Tabidze will report to VEON Group CEO Kaan Terzioglu.
  • Establishing this new role will strengthen the Group’s support to each of our operating companies in accelerating their digital operator roll-out, transforming our value proposition from traditional telcos to providers of digital experiences,” said Kaan Terzioglu, CEO of VEON Group.
  • “I am thrilled to rejoin VEON in the Group DO1440 Officer capacity,” said Lasha Tabidze.

VEON Joins BeSafe Campaign to Combat Human Trafficking Targeting Ukrainians

Retrieved on: 
Wednesday, March 8, 2023
VEON, Euronext Amsterdam, Woman, OSCE, United Nations, Security, UN, Thomson Reuters, United States Mission to the Organization for Security and Cooperation in Europe, Organization, Kyivstar, Drug

Amsterdam, 8 March 2023: VEON Ltd. (NASDAQ: VEON, Euronext Amsterdam: VEON), a global digital operator that provides converged connectivity and online services, today announces its support to “BeSafe” campaign to protect Ukrainian women and children from the risks of human trafficking.

Key Points: 
  • Amsterdam, 8 March 2023: VEON Ltd. (NASDAQ: VEON, Euronext Amsterdam: VEON), a global digital operator that provides converged connectivity and online services, today announces its support to “BeSafe” campaign to protect Ukrainian women and children from the risks of human trafficking.
  • To support the initiative, VEON provides technical aid while Kyivstar launches a messaging campaign that reaches displaced Ukrainians in countries of refuge, offering advice on how to report suspected trafficking and how to find help.
  • The messaging campaign focuses on individuals who have been displaced to particularly high-risk countries where known human trafficking is occurring.
  • The UN has also identified the displacement of Ukrainians as one of two new factors driving human trafficking activity on a global scale.

VEON confirms revised timing for effectiveness of ratio change under its American Depositary Receipt (“ADR”) program

Retrieved on: 
Tuesday, March 7, 2023
Euronext Amsterdam, Ratio, CUSIP, DTCC, ADR, ADS, VEON, Depository Trust & Clearing Corporation, Effective date, ADR Institute of Alberta, Nasdaq Market Makers Antitrust Litigation, BNY Mellon, Security (finance)

DTCC has now confirmed the availability of the new CUSIP, and the effective date of the Ratio Change (the “Effective Date”) is now confirmed as 8 March 2023.

Key Points: 
  • DTCC has now confirmed the availability of the new CUSIP, and the effective date of the Ratio Change (the “Effective Date”) is now confirmed as 8 March 2023.
  • American Depositary Share (“ADS”) beneficial holders who hold through an ADR holder intermediary need not take any action in connection with the Ratio Change.
  • For ADS holders, the Ratio Change will have the same effect as a one for twenty five reverse ADS split.
  • The Company’s original announcement with respect to the ratio change can be found on the Company’s website at this address:

Wolters Kluwer recognized as #1 in the Netherlands for gender diversity

Retrieved on: 
Tuesday, March 7, 2023
Partnership, Euronext Amsterdam, WEP, Gender, Woman, Workplace, UN, Wolters Kluwer, Talent management, UN Women, International, Workforce, World government, Bell, Senior, World Federation of Exchanges, Management

Third consecutive year the Company claims top spot in Equileap’s ranking;

Key Points: 
  • Third consecutive year the Company claims top spot in Equileap’s ranking;
    Alphen aan den Rijn, March 7, 2023 — Wolters Kluwer is the top company for gender diversity in the Netherlands, according to Equileap, a leading provider of data and insights on gender equality.
  • This is the third consecutive year that Wolters Kluwer has won the honor.
  • The independent recognition comes as Wolters Kluwer prepares to celebrate International Women’s Day at Euronext Amsterdam on March 8 for the Ring the Bell for Gender Equality 2023 campaign .
  • “At Wolters Kluwer we believe that diversity drives performance, and we are pleased to once again be recognized with the top ranking in the Netherlands for gender diversity,” says Carlos Rivero, Senior Vice President, Global Head of Talent Management at Wolters Kluwer.

VEON announces postponement to effectiveness of ratio change under its American Depositary Receipt (“ADR”) program

Retrieved on: 
Monday, March 6, 2023
Depository Trust & Clearing Corporation, DTCC, CUSIP, Euronext Amsterdam, BNY Mellon, VEON, Cryptocurrency, Security (finance)

Amsterdam, Netherlands, 6 March 2023 07:00 CET: VEON Ltd. (NASDAQ, Euronext Amsterdam: VEON) (“VEON” or the “Company”), a global digital operator that provides converged connectivity and online services, today provides an update on the timing of the ratio change under the Company’s ADR program, previously announced on 6 February 2023 and originally planned to become effective on 6 March 2023.

Key Points: 
  • Amsterdam, Netherlands, 6 March 2023 07:00 CET: VEON Ltd. (NASDAQ, Euronext Amsterdam: VEON) (“VEON” or the “Company”), a global digital operator that provides converged connectivity and online services, today provides an update on the timing of the ratio change under the Company’s ADR program, previously announced on 6 February 2023 and originally planned to become effective on 6 March 2023.
  • The Company was informed late afternoon on Friday 3 March 2023 by BNY Mellon that the ratio change effectiveness has been postponed as The Depository Trust & Clearing Corporation (“DTCC”) was not prepared to make the new CUSIP with new ratio available on Monday, 6 March 2023 as scheduled.
  • The Company awaits further confirmation from DTCC as to when it will be prepared to make the new CUSIP with new ratio available and will announce the new timing for effectiveness as soon as this is confirmed.
  • The Company’s original announcement with respect to the ratio change can be found on the Company’s website at this address: